Skip to main content

Want a detailed portfolio tracker?

XOMA Royalty (XOMA) P/E (2010 - 2026)

XOMA Royalty (XOMA) P/E from Dec 31, 2010 to Jul 14, 2026. The TTM XOMA Royalty (XOMA) P/E is 22.87. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of XOMA Royalty (XOMA)

YearP/EChange
202622.87+42.83%
202516.01-171.70%
2024-22.33+181.22%
2023-7.94-164.53%
202212.31-27.77%
202117.04-62.62%
202045.58-144.98%
2019-101.34+1177.56%
2018-7.93-73.31%
2017-29.72+1134.23%
2016-2.41-67.21%
2015-7.34-31.71%
2014-10.75+123.70%
2013-4.81+158.02%
2012-1.86+110.17%
2011-0.89-89.48%
2010-8.43N/A

Comparison XOMA Royalty (XOMA) P/E with competitors

XOMA Royalty (XOMA) P/E is 22.87.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.67%
FGENFibroGen Inc0.24-98.95%
CHRSCoherus Biosciences Inc0.85-96.29%
FBIOFortress Biotech Inc0.95-95.85%
ORMPOramed Pharmaceuticals Inc1.50-93.43%
AGENAgenus Inc3.01-86.84%
INVAInnoviva Inc3.15-86.21%
VXRTVaxart Inc3.55-84.48%
CRMDCorMedix Inc3.63-84.14%
CVACCureVac N.V.4.45-80.56%
GLPGGalapagos NV4.86-78.76%
SRPTSarepta Therapeutics Inc4.88-78.66%
ABEOAbeona Therapeutics Inc5.39-76.45%
ABUSArbutus Biopharma Corp5.60-75.54%
ZVRAZevra Therapeutics Inc5.89-74.26%
SPROSpero Therapeutics Inc6.23-72.77%
CGENCompugen Ltd6.31-72.40%
RIGLRigel Pharmaceuticals6.87-69.96%
SLXNSilexion Therapeutics Corp7.30-68.10%
OMEROmeros Corporation9.26-59.52%
AUPHAurinia Pharmaceuticals Inc9.58-58.10%
PLXProtalix BioTherapeutics Inc10.89-52.39%
ACADAcadia Pharmaceuticals Inc11.73-48.73%
TBPHTheravance Biopharma Inc12.26-46.39%
ADMAAdma Biologics Inc12.42-45.71%
HRMYHarmony Biosciences Holdings Inc13.82-39.58%
SABSSAB Biotherapeutics Inc14.14-38.20%
NAGENiagen Bioscience Inc14.82-35.22%
INCYIncyte Corp15.82-30.83%
REGNRegeneron Pharmaceuticals Inc15.86-30.68%
PBYIPuma Biotechnology Inc17.32-24.30%
CPRXCatalyst Pharmaceuticals Inc17.44-23.76%
EXELExelixis Inc17.54-23.33%
TGTXTG Therapeutics Inc18.97-17.09%
MDXGMimedx Group Inc20.55-10.15%
ARGXArgen X SE24.30+6.23%
CTMXCytomX Therapeutics Inc24.82+8.51%
XOMAOXOMA Royalty Corp25.34+10.80%
HALOHalozyme Therapeutics Inc25.62+12.02%
XOMAPXOMA Royalty Corp25.67+12.22%
VRTXVertex Pharmaceuticals Inc27.99+22.39%
RPRXRoyalty Pharma plc - Class A28.69+25.42%
SLNOSoleno Therapeutics Inc29.02+26.85%
ASNDAscendis Pharma A/S30.09+31.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91+65.74%
APLSApellis Pharmaceuticals Inc39.02+70.59%
BMRNBiomarin Pharmaceutical Inc42.21+84.54%
KRYSKrystal Biotech Inc45.34+98.23%
ONCBeiGene Ltd69.54+204.02%
PHARPharming Group N.V.75.03+228.00%
TECHBio-Techne Corp101.96+345.74%
VCELVericel Corp109.92+380.56%
ALNYAlnylam Pharmaceuticals Inc117.96+415.72%
GMABGenmab140.29+513.33%
TLXTelix Pharmaceuticals Ltd162.15+608.90%
CORTCorcept Therapeutics Inc212.86+830.57%